Hotgen(SH:688068) Xin Lang Cai Jing·2025-09-03 08:19Core Insights - Beijing Hotgen Biotech Co., Ltd. and its subsidiaries have obtained multiple qualifications, enhancing their product offerings and competitive edge [1] Group 1: Product Qualifications - The company has acquired 5 domestic medical device registration certificates, all for甲功检测 products, overcoming core raw material bottlenecks in small molecule sandwich assays, resulting in superior detection performance [1] - The company has also secured a filing for a cosmetic product named "Causen Gentle Awakening Cleansing Honey" [1] - Additionally, the company received a patent for "A gastric cancer diagnostic marker based on extracellular vesicle miRNA and its application" [1] - The company has obtained copyright for the software "Liver Cancer Risk Analysis Software 1.0" [1] Group 2: Business Impact - These qualifications enrich the company's product variety, enhance its business scope and intellectual property system, and improve its competitiveness [1] - However, product sales are influenced by various factors, leading to uncertainties [1]